# EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/egfr-mutation-status-in-tumour-derived-dna-from-pleural-effusion-fluid-is-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hideki Kimura,Yutaka Fujiwara,T. Sone,Hideo Kunitoh,Tomohide Tamura,Kazuo Kasahara,Kazuto Nishio |
| Citations | 126 |
| DOI | 10.1038/sj.bjc.6603428 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/6603428.pdf |
| OpenAlex ID | https://openalex.org/W2041738335 |
| PMID | 17060940 |
| Type | article |
| Year | 2006 |

## Paper authors

- [Yutaka Fujiwara](https://scholariq.org/researchers/yutaka-fujiwara/)

## Paper journal

- [British Journal of Cancer](https://scholariq.org/journals/british-journal-of-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.